Structure-activity relationships of 6-(heterocyclyl)-methylene penam sulfones. A new class of .BETA.-lactamase inhibitors.
Yuhpyng L. Chen(Institute of Medicinal Plant Development), John F. Barrett(Pfizer (United States)), Cnm-Wu CHANG(Institute of Medicinal Plant Development), Laura L. Kiessling(Massachusetts Institute of Technology), MARY MANOUSOS(Pfizer (United States)), K. HEDBERG(Institute of Medicinal Plant Development), MARGARET R. ANDERSON(Pfizer (United States)), James A. Retsema(Pfizer (United States)), Karen J. Guarino(Institute of Medicinal Plant Development), Willard M. Welch(Institute of Medicinal Plant Development), S L Haskell(Pfizer (United States))
Cited by 38
Related Papers
How many human proteoforms are there?
|Nature Chemical Biology|2018|942
Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms
|Antimicrobial Agents and Chemotherapy|1987|461
CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization
|Antimicrobial Agents and Chemotherapy|1978|397
<b>Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, <i>mefA</i>, from <i>Streptococcus pyogenes</i></b>
|Molecular Microbiology|1996|360
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution
|Antimicrobial Agents and Chemotherapy|1987|323